Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-20 | New | $3,999,999 | $3,999,999 | Equity Only | 06b | SEC link |
| 2022-10-14 | New | $4,260,617 | $4,260,617 | Equity Only | 06b | SEC link |
| 2020-12-18 | Amended | $20,296,275 | $10,297,905 | Equity Only | 06b | SEC link |
| 2019-01-10 | New | $9,998,370 | $9,998,370 | Equity Only | 06b | SEC link |
| 2018-11-20 | New | $999,284 | $999,284 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Enrique J Carrazana | Director |
| Didric Cederholm | Director |
| Steven F Lincoln | Executive |
| Brendan Magrab | Director, Executive |
| Randall Murphy | Director |
| Arthur Franklin Rice | Director, Executive |
| Michael Rogawski | Director |
| Jon S. Saxe | Director |
| Matthew Smith | Director |